Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
deals
life sciences
national blog main
new york blog main
2
×
raleigh-durham blog main
san diego blog main
san francisco blog main
san francisco top stories
2
×
seattle blog main
seattle top stories
10x genomics
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
astellas pharma
avrobio
becton dickinson
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brexanolone
camp4 therapeutics
cancer diagnostics
cancer immunotherapy
clinical trials
crispr therapeutics
crispr-cas9
denali therapeutics
detroit blog main
detroit top stories
diagnostic device
eidos therapeutics
estradiol
f-star gamma
fda
food and drug administration
gene editing
What
reach
2
×
adding
ahead
aims
ambien
american
annual
asco
attendees
attention
biotech
camp’s
cancer
cash
chicago
city
clinical
combinations
community’s
company
days
deal
decisions
diagnostic
diagnostics
drug
expand
expanding
focus
fold
help
home
key
kicks
make
meeting
nanostring
oncology
oncology’s
physicians
Language
unset
Current search:
reach
×
" new york blog main "
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More